Resurgent currents in human dorsal root ganglia

Ended Project Grant Awarded Last action

Award ID
F32NS131253
Recipient
Awarding agency
Obligated
$279,548

Award facts

Completion date
Place of performance
Texas, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Voltage-gated sodium channels (vgscs) are critical gatekeepers of nociceptor excitability. In nociceptors, vgscs are required for nociception, chronic pain, and their increased function causes pain without injury. Most of our knowledge of vgscs in nociceptors and their alterations in chronic pain come from rodent and heterologous expression system studies. However, emergent studies on human dorsal root ganglia reveal prominent species differences in vgsc expression, kinetics, pharmacology, and modulation. Thus, the premise of this study is to thoroughly characterize unique sodium currents biophysics in human dorsal root ganglia (DRG) neurons, which will identify novel therapeutic targets and lead to the development of nonopioid analgesics. Our recent spatial sequencing studies revealed that SS4 is highly expressed in all human dorsal root ganglia neurons but, in mice, confined to large-diameter neurons and c-low threshold mechanoreceptors, which are generally non-nociceptive. Half of large-diameter, but not small-diameter (generally nociceptive), murine DRG neurons exhibited resurgent current. This strongly suggests that human nociceptors generate resurgent currents. Focusing on interactions between vgscs and their known modulators, i will determine whether human nociceptors display resurgent sodium currents, if resurgent currents are potentiated by nociceptor sensitization, and if they are driven, at least in part, by intracellular interactions between vgscs and NAVSS4 and/or fgfs. In nociceptors, resurgent sodium currents may dramatically increase neuronal activity by augmenting spontaneous activity, evoking persistent current, and mediating repetitive firing. In the context of pain, resurgent sodium currents may convert mild nociceptor activation to trains of action potentials that can provoke intense pain and lead to activity-dependent plasticity in central synapses. To address my hypothesis, i will exclusively use human dorsal root ganglia from organ donors. Aim 1 will use bioinformatics to thoroughly characterize vgsc and modulator expression in human nociceptors. Aim 2 will employ patch-clamp electrophysiology to characterize tetrodotoxin (TTX)-resistant and -sensitive resurgent currents in human nociceptors. Aim 3 will model sensitization dependent voltage-gated sodium channel binding to modulators and examine sensitization-specific isoforms. This work will elucidate how unique expression patterns of vgscs and their modulating proteins contribute to nociceptor sodium current, which is essential for understanding human nociception. This training opportunity will leverage advanced training in human molecular neuroscience that can only be done in a few labs in the world, guided by experts in sequencing technologies, electrophysiology and bioinformatics, and will prepare me for an independent academic career.

Transactions

Action Obligated Date
Amendment -$8,020
Amendment $4,784
Amendment $4,784
Amendment $69,500
Amendment $0
Amendment $69,500
Amendment $69,500
Amendment $0
Amendment $69,500
Original award $0

Quick answers

Who received award F32NS131253?

F32NS131253 was awarded to University Of Texas At Dallas by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 8, 2024.

How much is award F32NS131253 worth?

$279,548 has been obligated on F32NS131253.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login